This page in English

Marie Arsenian-Henriksson

Professor

Besöksadress : Nobels Väg 16 171 77 Stockholm
Postadress : Institutionen för mikrobiologi, tumör- och cellbiologi (MTC), C1, Marie Arsenian Henriksson grupp, Box 280 171 77 Stockholm

Publikationer

Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients
Ribeiro D, Klarqvist Md, Westermark Uk, Oliynyk G, Dzieran J, Kock A, et al
Cell reports 2016;16(4):979-93

Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC
Romeo Mm, Ko B, Kim J, Brady R, Heatley Hc, He J, et al
Virology 2015;476():271-88

COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset
Larsson K, Kock A, Idborg H, Arsenian Henriksson M, Martinsson T, Johnsen Ji, et al
Proceedings of the National Academy of Sciences of the United States of America 2015;112(26):8070-5

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
Wang H, Teriete P, Hu A, Raveendra-panickar D, Pendelton K, Lazo Js, et al
Oncotarget 2015;6(32):32380-95

Impact of MYC in regulation of tumor cell metabolism
Wahlström T, Henriksson Ma
Biochimica et biophysica acta 2015;1849(5):563-9

TAp73 suppresses tumor angiogenesis through repression of proangiogenic cytokines and HIF-1α activity
Stantic M, Sakil Ha, Zirath H, Fang T, Sanz G, Fernandez-woodbridge A, et al
Proceedings of the National Academy of Sciences of the United States of America 2015;112(1):220-5

MYC proteins promote neuronal differentiation by controlling the mode of progenitor cell division
Zinin N, Adameyko I, Wilhelm M, Fritz N, Uhlén P, Ernfors P, et al
EMBO reports 2014;15(4):383-91

Targeting of the MYCN protein with small molecule c-MYC inhibitors
Müller I, Larsson K, Frenzel A, Oliynyk G, Zirath H, Prochownik Ev, et al
PloS one 2014;9(5):e97285-

X-ray phase contrast with injected gas for tumor microangiography
Lundström U, Westermark Uk, Larsson Dh, Burvall A, Arsenian Henriksson M, Hertz Hm
Physics in medicine and biology 2014;59(11):2801-11

Chromatin dynamics at the hTERT promoter during transcriptional activation and repression by c-Myc and Mnt in Xenopus leavis oocytes
Wahlström T, Belikov S, Arsenian Henriksson M
Experimental cell research 2013;319(20):3160-9

First application of liquid-metal-jet sources for small-animal imaging: High-resolution CT and phase-contrast tumor demarcation
Larsson Dh, Lundstrom U, Westermark Uk, Henriksson Ma, Burvall A, Hertz Hm
MEDICAL PHYSICS 2013;40(2):21909-

MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells
Zirath H, Frenzel A, Oliynyk G, Segerström L, Westermark Uk, Larsson K, et al
Proceedings of the National Academy of Sciences of the United States of America 2013;110(25):10258-63

MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma
Sonkoly E, Lovén J, Xu N, Meisgen F, Wei T, Brodin P, et al
Oncogenesis 2012;1():e3-

X-ray phase-contrast CO2 angiography for sub-10 mu m vessel imaging
Lundstrom U, Larsson Dh, Burvall A, Scott L, Westermark Uk, Wilhelm M, et al
PHYSICS IN MEDICINE AND BIOLOGY 2012;57(22):7431-41

Identification of Cytotoxic Drugs That Selectively Target Tumor Cells with MYC Overexpression
Frenzel A, Zirath H, Vita M, Albihn A, Henriksson Ma
PLOS ONE 2011;6(11):e27988-

Neuroblastoma research progress - A 2011 perspective
Henriksson Ma, Pahlman S
SEMINARS IN CANCER BIOLOGY 2011;21(4):215-6

The MYCN oncogene and differentiation in neuroblastoma
Westermark Uk, Wilhelm M, Frenzel A, Henriksson Ma
SEMINARS IN CANCER BIOLOGY 2011;21(4):256-66

Chromosomal rearrangements after ex vivo Epstein-Barr virus (EBV) infection of human B cells
Lacoste S, Wiechec E, Silva Agd, Guffei A, Williams G, Lowbeer M, et al
ONCOGENE 2010;29(4):503-15

Isoform-specific p73 knockout mice reveal a novel role for Delta Np73 in the DNA damage response pathway
Wilhelm Mt, Rufini A, Wetzel Mk, Tsuchihara K, Inoue S, Tomasini R, et al
GENES & DEVELOPMENT 2010;24(6):549-60

MYC in Oncogenesis and as a Target for Cancer Therapies
Albihn A, Johnsen Ji, Henriksson Ma
ADVANCES IN CANCER RESEARCH, VOL 107 2010;:163-224

Myc Is Required for Activation of the ATM-Dependent Checkpoints in Response to DNA Damage
Guerra L, Albihn A, Tronnersjo S, Yan Qz, Guidi R, Stenerlow B, et al
PLOS ONE 2010;5(1):e8924-

MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma
Loven J, Zinin N, Wahlstrom T, Muller I, Brodin P, Fredlund E, et al
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2010;107(4):1553-8

Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation
Hydbring P, Bahram F, Su Yt, Tronnersjo S, Hogstrand K, Von Der Lehr N, et al
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2010;107(1):58-63

Targeting MYC-Regulated miRNAs to Combat Cancer
Frenzel A, Lovén J, Henriksson Ma
Genes & cancer 2010;1(6):660-7

The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy
Larsson Lg, Henriksson Ma
EXPERIMENTAL CELL RESEARCH 2010;316(8):1429-37

DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1
Lerner M, Harada M, Loven J, Castro J, Davis Z, Oscier D, et al
EXPERIMENTAL CELL RESEARCH 2009;315(17):2941-52

Embryonal neural tumours and cell death
Johnsen J, Kogner P, Albihn A, Henriksson M
APOPTOSIS 2009;14(4):424-38

Identification of recognition sites for Myc/Max/Mxd network proteins by a whole human chromosome 19 selection strategy
Akopov S, Chernov I, Wahlstrom T, Kostina M, Klein G, Henriksson M, et al
BIOCHEMISTRY-MOSCOW 2008;73(11):1260-8

Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo
Johnsen Ji, Segerstrom L, Orrego A, Elfman L, Henriksson M, Kagedal B, et al
ONCOGENE 2008;27(20):2910-22

Role of Myc in differentiation and apoptosis in HL60 cells after exposure to arsenic trioxide or all-trans retinoic acid
Jiang Gs, Albihn A, Tang Th, Tian Zg, Henriksson M
LEUKEMIA RESEARCH 2008;32(2):297-307

Camptothecin-induced apoptosis is enhanced by Myc and involves PKCdelta signaling
Albihn A, Mo H, Yang Y, Henriksson M
INTERNATIONAL JOURNAL OF CANCER 2007;121(8):1821-9

Mnt takes control as key regulator of the Myc/Max/Mxd network
Wahlstrom T, Henriksson M
ADVANCES IN CANCER RESEARCH, VOL 97 2007;:61-80

Open-ended assignments and student responsibility
Brauner A, Carey J, Henriksson M, Sunnerhagen M, Ehrenborg E
BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION 2007;35(3):187-92

25 years of the c-Myc oncogene
Cole Md, Henriksson M
SEMINARS IN CANCER BIOLOGY 2006;16(4):241-

c-Myc-dependent etoposide-induced apoptosis involves activation of Bax and caspases, and PKCdelta signaling
Albihn A, Loven J, Ohlsson J, Osorio Lm, Henriksson M
JOURNAL OF CELLULAR BIOCHEMISTRY 2006;98(6):1597-614

Identification of small molecules that induce apoptosis in a Myc-dependent manner and inhibit Myc-driven transformation
Mo H, Henriksson M
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2006;103(16):6344-9

Myc overexpression enhances apoptosis induced by small molecules
Mo H, Vita M, Crespin M, Henriksson M
CELL CYCLE 2006;5(19):2191-4

The Myc oncoprotein as a therapeutic target for human cancer
Vita M, Henriksson M
SEMINARS IN CANCER BIOLOGY 2006;16(4):318-30

Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II
Stavropoulou V, Xie Jj, Henriksson M, Tomkinson B, Imreh S, Masucci Mg
CANCER RESEARCH 2005;65(4):1361-8

Mnt transcriptional repressor is functionally regulated during cell cycle progression
Popov N, Wahlstrom T, Hurlin Pj, Henriksson M
ONCOGENE 2005;24(56):8326-37

Biophysical properties of regions flanking the bHLH-Zip motif in the p22 Max protein
Pursglove Se, Fladvad M, Bellanda M, Moshref A, Henriksson M, Carey J, et al
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2004;323(3):750-9

Expression and DNA-binding activity of MYCN/max and Mnt/max during induced differentiation of human neuroblastoma cells
Smith Ag, Popov N, Imreh M, Axelson H, Henriksson M
JOURNAL OF CELLULAR BIOCHEMISTRY 2004;92(6):1282-95

Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: Activation of the Epiregulin gene
Lindvall C, Hou M, Komurasaki T, Zheng Cy, Henriksson M, Sedivy Jm, et al
CANCER RESEARCH 2003;63(8):1743-7

The herpes simplex virus-1 Us3 protein kinase blocks CD8T cell lysis by preventing the cleavage of Bid by granzyme B
Cartier A, Broberg E, Komai T, Henriksson M, Masucci Mg
CELL DEATH AND DIFFERENTIATION 2003;10(12):1320-8

The Mad and Myc basic domains are functionally equivalent
Nikiforov Ma, Popov N, Kotenko I, Henriksson M, Cole Md
JOURNAL OF BIOLOGICAL CHEMISTRY 2003;278(13):11094-9

c-myc suppression in Burkitt's lymphoma cells
Simonsson T, Henriksson M
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2002;290(1):11-5

Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1
Cerni C, Skrzypek B, Popov N, Sasgary S, Schmidt G, Larsson Lg, et al
ONCOGENE 2002;21(3):447-59

The histone deacetylase inhibitor trichostatin a derepresses the telomerase reverse transcriptase (hTERT) gene in human cells
Hou M, Wang Xb, Popov N, Zhang Aj, Zhao Xy, Zhou R, et al
EXPERIMENTAL CELL RESEARCH 2002;274(1):25-34

Differential expression of class IHDACs: Roles of cell density and cell cycle
Dangond F, Henriksson M, Zardo G, Caiafa P, Ekstrom Tj, Gray Sg
INTERNATIONAL JOURNAL OF ONCOLOGY 2001;19(4):773-7

Horizontal transfer of oncogenes by uptake of apoptotic bodies
Bergsmedh A, Szeles A, Henriksson M, Bratt A, Folkman Mj, Spetz Al, et al
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2001;98(11):6407-11

Inactivation of Myc-induced p53-dependent apoptosis in human tumors
Henriksson M, Selivanova G, Lindstrom M, Wiman Kg
APOPTOSIS 2001;6(1-2):133-7

Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells
Xu Dw, Popov N, Hou M, Wang Q, Bjorkholm M, Gruber A, et al
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2001;98(7):3826-31

Frequent amplification of the Telomerase Reverse Transcriptase gene in human tumors
Zhang Aj, Zheng Cy, Lindvall C, Hou M, Ekedahl J, Lewensohn R, et al
CANCER RESEARCH 2000;60(22):6230-5

Inhibition of cell growth and apoptosis by inducible expression of the transcriptional repressor Mad1
Bejarano Mt, Albihn A, Cornvik T, Brijker So, Asker C, Osorio Lm, et al
EXPERIMENTAL CELL RESEARCH 2000;260(1):61-72

Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation
Luscher-firzlaff Jm, Westendorf Jm, Zwicker J, Burkhardt H, Henriksson M, Muller R, et al
ONCOGENE 1999;18(41):5620-30

Regulation of cell growth by the Myc-Max-Mad network: Role of Mad proteins and YY1
Austen M, Cerni C, Henriksson M, Hilfenhaus S, Luscherfirzlaff Jm, Menkel A, et al
C-MYC IN B-CELL NEOPLASIA 1997;:123-30

Proteins of the Myc network: Essential regulators of cell growth and differentiation
Henriksson M, Luscher B
ADVANCES IN CANCER RESEARCH, VOL 68 1996;:109-82

DIFFERENTIAL-EFFECTS BY MAD AND MAX ON TRANSFORMATION BY CELLULAR AND VIRAL ONCOPROTEINS
Cerni C, Bousset K, Seelos C, Burkhardt H, Henriksson M, Luscher B
ONCOGENE 1995;11(3):587-96

The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas
Axelson H, Henriksson M, Wang Y, Magnusson Kp, Klein G
EUROPEAN JOURNAL OF CANCER 1995;31A(12):2099-104

Visa alla publikationer